Lipid nanoparticles incorporating DOTAP and DOPE enable serial mRNA transfection of primary human T cells with significantly improved viable cell yields compared to standard electroporation. This platform supports iterative functional modifications across multiple rounds of delivery while preserving cell viability, facilitating the manufacturing of complex, multi-payload cell therapies.